Switzerland

Thumbnail for Vestergaard welcomes Dr. Jackline Martin through I2I Placement Programme to advance vector control

13 February 2025

Vestergaard welcomes Dr. Jackline Martin through I2I Placement Programme to advance vector control

Thumbnail for Novartis to acquire Anthos Therapeutics for US$925M

13 February 2025

Novartis to acquire Anthos Therapeutics for US$925M

Thumbnail for Vestergaard renews fight against sleeping sickness with tiny targets donation

3 February 2025

Vestergaard renews fight against sleeping sickness with tiny targets donation

Thumbnail for WHO prequalifies first diagnostic test for G6PD deficiency

9 January 2025

WHO prequalifies first diagnostic test for G6PD deficiency

Thumbnail for Medacta’s NextAR Augmented Reality Surgical Platform expands to anatomic shoulder procedures

29 November 2024

Medacta’s NextAR Augmented Reality Surgical Platform expands to anatomic shoulder procedures

Thumbnail for Roche to acquire Poseida Therapeutics in a US$1.5B deal

27 November 2024

Roche to acquire Poseida Therapeutics in a US$1.5B deal

Thumbnail for WHO approves Cecolin® for single-dose HPV vaccination

7 October 2024

WHO approves Cecolin® for single-dose HPV vaccination

Thumbnail for Medacta partners with THINK Surgical for robotic knee replacements

4 September 2024

Medacta partners with THINK Surgical for robotic knee replacements

Thumbnail for Novartis’ Fabhalta receives FDA approval for treatment of rare kidney disorder

9 August 2024

Novartis’ Fabhalta receives FDA approval for treatment of rare kidney disorder

Thumbnail for Roche halts lung cancer trial after disappointing immunotherapy results

5 July 2024

Roche halts lung cancer trial after disappointing immunotherapy results